首页> 外文期刊>Carbohydrate Polymers: Scientific and Technological Aspects of Industrially Important Polysaccharides >Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation
【24h】

Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation

机译:基于羟丙基甲基纤维素的控制释放剂量通过熔融挤出和3D印刷:结构和药物释放相关性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The objective of this study was to develop a new approach for fabrication of zero order release of active pharmaceutical ingredients (APIs) using hot-melt extrusion (HME) and 3D printing technology to generate tablets with specific 3D structures. By correlating the geometry of the 3D printed tablets with their dissolution and drug release rates, mathematical models that have been developed to describe drug release mechanisms were also studied. Acetaminophen was used as a model drug, and Benecel (TM) hydroxypropyl methylcellulose (HPMC) E5 and Soluplus (R) were used to formulate nine fuse depositional 3D-printed tablets with different inner core fill densities and outside shell thicknesses. This work reports the successful fabrication of solid-dispersion filaments with an API dispersed in HPMC based matrix via HME technology, and the production of zero order controlled release tablets with different 3D structures (tablets #3, 5, 6, and 9) using a 3D printer.
机译:本研究的目的是利用热熔挤出(HME)和3D印刷技术来开发一种用于制备活性药物成分(API)的零阶释放的新方法,以产生具有特定3D结构的片剂。 通过将3D印刷片剂的几何形状与其溶解和药物释放速率相关,还研究了已经开发出描述药物释放机制的数学模型。 乙酰氨基酚用作模型药物,并且苯二克(TM)羟丙基甲基纤维素(HPMC)E5和Soluplus(r)用于配制九个熔丝沉积3D印刷片,其具有不同的内核填充密度和外壳厚度。 该工作报告通过HME技术将固体分散细丝的固体分散细丝的成功制造具有分散在HPMC基基质中的API,以及使用不同的3D结构(片剂#3,5,6和9)的零级控制释放片的生产 3D打印机。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号